Reference SummarySheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76
Title |
Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. | ||||
Authors |
Sheldon WG; Bucci TJ; Hart RW; Turturro A | ||||
Journal |
Toxicol Pathol | ||||
Volume |
23 | ||||
Issue |
4 | ||||
Year |
1995 | ||||
Pages |
458-76 | ||||
Abstract |
Longevity, body weight, and age-specific neoplasia were determined in 1,064 B6C3F1 mice as part of a coordinated study of food restriction (FR). Restricted animals were offered 60% of the diet consumed by the ad libitum (AL) group. Longevity data were derived from a set of 56 animals of each sex from each diet group, which were examined whenever dead or moribund. For cross-sectional data, a parallel set of 210 animals were sacrificed in groups of 12-15 at 6-mo intervals. Lifetime body weight was reduced in the FR mice approximately proportional to restriction (i.e., 40%). Food restriction increased the age at 50% survival (median) by 36% in both sexes and increased the maximal lifespan (mean age of oldest 10%) by 21.5% in males and by 32.5% in females. In 56 males of the longevity groups, there were 89 neoplasms in the AL subgroup versus 53 in FR; 56 AL females had 100, versus 58 in 55 FR females. Increase in lifespan of the restricted animals was achieved primarily by decrease in incidence and delay of onset of fatal tumors, of which lymphoma was the most prominent. This report catalogs all of the neoplasms (1,103) observed in longevity and cross-sectional groups, by diet, sex, and age. These data add to the existing knowledge base needed for future studies of dietary restriction and aging as well to evaluate nutrition of animals used in bioassays. | ||||
Links |
J:31053 – MGI References 7501958 – National Library of Medicine/PubMed |
||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
(C57BL/6N x C3H/HeN)F1 | Adipose tissue liposarcoma |
|
Skin |
33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
1.4 - 12.5 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Cortex adenoma |
|
Adrenal gland - Cortex |
2.3 - 6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
4.5 - 14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
2.5 - 13.3 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel neoplasm | Blood vessel |
0 - 31.25 |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel neoplasm |
|
Blood vessel |
0 - 100 |
|
(C57BL/6N x C3H/HeN)F1 | Bone osteosarcoma | Bone |
3.1 - 50 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteosarcoma |
|
Bone |
2.5 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | CNS - Brain - Oligodendroglial cell oligodendroglioma | CNS - Brain - Oligodendroglial cell |
6.25 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibrosarcoma | Skin |
3.1 - 12.5 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibrosarcoma |
|
Skin |
13.3 |
|
(C57BL/6N x C3H/HeN)F1 | Ear - Zymbal gland carcinoma | Ear - Zymbal gland |
7.1 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland adenocarcinoma | Eye - Harderian gland |
1.4 - 5.9 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland adenoma | Eye - Harderian gland |
3.1 - 35.7 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland adenoma |
|
Eye - Harderian gland |
2.9 - 23.1 |
|
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland carcinoma | Eye - Harderian gland |
4.8 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 - 35.7 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland neoplasm |
|
Eye - Harderian gland |
0 - 23.1 |
|
(C57BL/6N x C3H/HeN)F1 | Intestine - Large Intestine carcinoma | Intestine - Large Intestine |
12.5 |
||
(C57BL/6N x C3H/HeN)F1 | Intestine - Large Intestine polyp | Intestine - Large Intestine |
12.5 |
||
(C57BL/6N x C3H/HeN)F1 | Intestine - Small Intestine polyp | Intestine - Small Intestine |
1.4 |
||
(C57BL/6N x C3H/HeN)F1 | Intestine - Small Intestine polyp |
|
Intestine - Small Intestine |
3.8 - 10 |
|
(C57BL/6N x C3H/HeN)F1 | Kidney - Cortex adenocarcinoma |
|
Kidney - Cortex |
2.5 - 3.8 |
|
(C57BL/6N x C3H/HeN)F1 | Kidney - Cortex adenoma |
|
Kidney - Cortex |
2.5 - 23.1 |
|
(C57BL/6N x C3H/HeN)F1 | Kidney - Cortex adenoma | Kidney - Cortex |
14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Kidney neoplasm | Kidney |
0 - 14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Kidney neoplasm |
|
Kidney |
0 - 25 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 28.6 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 44.4 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor |
|
Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia | Leukocyte - Myelocyte (Granulocyte) |
12.5 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia |
|
Leukocyte - Myelocyte (Granulocyte) |
50 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma | Leukocyte |
0 - 84.2 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma |
|
Leukocyte |
0 - 100 |
|
(C57BL/6N x C3H/HeN)F1 | Liver - Sinusoid - Ito cell neoplasm | Liver - Sinusoid - Ito cell |
6.7 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma | Liver |
4.1 - 50 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma |
|
Liver |
2.3 - 20 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma | Liver |
5.0 - 100 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma |
|
Liver |
2.9 - 30 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular neoplasm | Liver |
12.0 - 35.9 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular neoplasm |
|
Liver |
6.5 - 6.8 |
|
(C57BL/6N x C3H/HeN)F1 | Liver neoplasm | Liver |
0 - 53.3 |
||
(C57BL/6N x C3H/HeN)F1 | Liver neoplasm |
|
Liver |
0 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Lung adenoma | Lung |
4.5 - 42.9 |
||
(C57BL/6N x C3H/HeN)F1 | Lung adenoma |
|
Lung |
5.0 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma | Lung |
3.1 - 50 |
||
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma |
|
Lung |
1.9 - 11.1 |
|
(C57BL/6N x C3H/HeN)F1 | Lung neoplasm | Lung |
0 - 71.4 |
||
(C57BL/6N x C3H/HeN)F1 | Lung neoplasm |
|
Lung |
0 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Mammary gland adenocarcinoma | Mammary gland |
0 - 35.7 |
||
(C57BL/6N x C3H/HeN)F1 | Mammary gland adenocarcinoma |
|
Mammary gland |
0 - 5.3 |
|
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Skin |
2.1 - 18.2 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma |
|
Liver |
6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma |
|
Skin |
6.7 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
2.1 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Gallbladder |
2.9 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma - poorly differentiated | Muscle - Striated - Skeletal |
1.4 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma - poorly differentiated |
|
Muscle - Striated - Skeletal |
2.5 - 5.3 |
|
(C57BL/6N x C3H/HeN)F1 | Mesothelium mesothelioma | Abdominal cavity |
5.3 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyoma | Uterus |
1.4 - 7.7 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma | Intestine |
3.1 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma | Uterus |
1.4 - 10.5 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma |
|
Uterus |
6.7 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
1.4 - 5.9 |
||
(C57BL/6N x C3H/HeN)F1 | Nose squamous cell carcinoma |
|
Nose |
3.7 |
|
(C57BL/6N x C3H/HeN)F1 | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
7.1 - 50 |
|
(C57BL/6N x C3H/HeN)F1 | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
3.1 - 10.5 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
6.7 - 14.3 |
|
(C57BL/6N x C3H/HeN)F1 | Ovary adenoma - cystic papillary | Ovary |
1.4 - 7.1 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary adenoma - cystic papillary |
|
Ovary |
14.3 |
|
(C57BL/6N x C3H/HeN)F1 | Ovary adenoma - tubular |
|
Ovary |
2.9 |
|
(C57BL/6N x C3H/HeN)F1 | Ovary luteoma | Ovary |
3.1 - 5.3 |
||
(C57BL/6N x C3H/HeN)F1 | PNS - Ganglion - Paraganglion chemodectoma | PNS - Ganglion - Paraganglion |
14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans |
4.5 - 4.8 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
2.3 - 6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans carcinoma |
|
Pancreas - Islet of Langerhans |
2.3 - 3.8 |
|
(C57BL/6N x C3H/HeN)F1 | Parathyroid gland adenoma | Parathyroid gland |
6.25 |
||
(C57BL/6N x C3H/HeN)F1 | Penis squamous cell carcinoma |
|
Penis |
3.8 |
|
(C57BL/6N x C3H/HeN)F1 | Peritoneum - Mesentery neoplasm - malignant - anaplastic | Abdominal cavity |
3.1 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland - Pars distalis adenoma | Pituitary gland - Pars distalis |
0 - 100 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland - Pars distalis adenoma |
|
Pituitary gland - Pars distalis |
0 - 13.3 |
|
(C57BL/6N x C3H/HeN)F1 | Skin - Hair follicle - Basal cell trichoepithelioma | Skin - Hair follicle - Basal cell |
5.3 |
||
(C57BL/6N x C3H/HeN)F1 | Skin carcinoma - basosquamous | Skin |
2.7 - 14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Skin squamous cell carcinoma |
|
Skin |
5.0 |
|
(C57BL/6N x C3H/HeN)F1 | Stomach adenocarcinoma |
|
Stomach |
10 |
|
(C57BL/6N x C3H/HeN)F1 | Stomach papilloma | Stomach |
2.9 - 100 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach papilloma |
|
Stomach |
6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Stomach squamous cell carcinoma | Stomach |
6.7 - 14.3 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach squamous cell carcinoma |
|
Stomach |
6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
6.25 |
||
(C57BL/6N x C3H/HeN)F1 | Testis - Leydig cell (Interstitial cell) adenoma |
|
Testis - Leydig cell (Interstitial cell) |
7.7 |
|
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0 - 29.4 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell adenoma |
|
Thyroid gland - Follicular cell |
0 - 6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Medulla - C cell carcinoma |
|
Thyroid gland - Medulla - C cell |
5.0 - 33.3 |
|
(C57BL/6N x C3H/HeN)F1 | Thyroid gland neoplasm | Thyroid gland |
0 - 12.0 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland neoplasm |
|
Thyroid gland |
0 - 2.6 |
|
(C57BL/6N x C3H/HeN)F1 | Tongue squamous cell carcinoma | Tongue |
3.1 - 7.1 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus polyp | Uterus |
1.4 - 21.4 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus polyp |
|
Uterus |
2.9 |
|
(C57BL/6N x C3H/HeN)F1 | Vagina squamous cell carcinoma |
|
Vagina |
6.7 |
|
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) neoplasm | (Unspecified organ) |
0 - 100 |
||
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) neoplasm |
|
(Unspecified organ) |
0 - 100 |
|
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) neoplasm - malignant - anaplastic | (Unspecified organ) |
observed |